SCHEMBL7428282

SCHEMBL7428282

CC(=O)c1ccc(NC(=O)C(F)(F)F)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.60
KMT2A Q03164 4/20 0.56
RAB9A P51151 3/20 0.56
MEN1 O00255 3/20 0.56
ALDH1A1 P00352 3/20 0.56
NPC1 O15118 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
TAAR1 Q96RJ0 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA9 Q16790 1/20 0.54
HTT P42858 1/20 0.53
NLRP1 Q9C000 1/20 0.53
EPHX2 P34913 1/20 0.52
NR1H4 Q96RI1 1/20 0.52
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8782956 0.82 L3MBTL1 (0.76) MAPTKMT2ARAB9AMEN1ALDH1A1
SCHEMBL434636 0.82 CA12 (0.56) MAPTKMT2ARAB9AMEN1ALDH1A1
SCHEMBL1542356 0.81 MEN1 (0.61) MAPTKMT2ARAB9AMEN1ALDH1A1
SCHEMBL27893900 0.81 L3MBTL1 (0.55) MAPTKMT2ARAB9AMEN1ALDH1A1
SCHEMBL6929094 0.81 MAPT (0.58) MAPTKMT2ARAB9AMEN1ALDH1A1
SCHEMBL19317529 0.81 L3MBTL1 (0.54) MAPTKMT2ARAB9AMEN1ALDH1A1
SCHEMBL7428266 0.81 CA12 (0.54) MAPTKMT2ARAB9AMEN1ALDH1A1
SCHEMBL25845706 0.81 CA12 (0.59) MAPTKMT2ARAB9AMEN1ALDH1A1
SCHEMBL1875367 0.80 L3MBTL1 (0.73) MAPTKMT2ARAB9AMEN1ALDH1A1
SCHEMBL28438301 0.80 MAPT (0.59) MAPTKMT2ARAB9AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010137350-A1 AGENT FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH ACTIVITY OF NEUROTROPHIC FACTORS 住友化学株式会社 (JP) 2010-12-02 WO disclosed
EP-0702013-B1 Imidazopyridines MERCK PATENT GMBH (DE) 2001-06-13 EP disclosed
US-6180411-B1 CHROMOPHORE INCORPORATING A PHOTOLABILE GROUP CAPABLE OF UNDERGOING AN IRREVERSIBLE AND DETECTABLE INTRAMOLECULAR TRANSFORMATION; CHROMOPHORE IS LINKED TO BINDING SITE FOR ANALYTE; FOR INTRACELLUAR ANALYSIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-01-30 US disclosed
US-5684015-A ANGIOTENSIN ANTAGONIST AS HYPOTENSIVE AGENTS AND CARDIOVASCULAR DISORDERS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1997-11-04 US disclosed
EP-0702013-A2 Imidazopyridines MERCK PATENT GmbH (DE) 1996-03-20 EP disclosed
US-5438063-A Hypotensive agents, cardiac insufficiency, increased intraocular pressure, and CNS disorders MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1995-08-01 US disclosed
EP-0657454-A1 Imidazopyridazines being angiotensin II antagonists MERCK PATENT GmbH (DE) 1995-06-14 EP disclosed
US-5389642-A Exhibit antagonistic properties toward angiotensin(II); useful for treatment of hypertensioni, aldosteronism, cardiac insufficiency, increased intraocular pressure and disorders of the central nervous system MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1995-02-14 US disclosed
EP-0628556-A1 Imidazopyridines MERCK PATENT GmbH (DE) 1994-12-14 EP disclosed
EP-0602521-A1 Imidazopyridines MERCK PATENT GmbH (DE) 1994-06-22 EP disclosed
EP-0547514-A2 Imidazopyridine derivatives with angiotensin-II antagonist properties MERCK PATENT GmbH (DE) 1993-06-23 EP disclosed